Stemline Therapeutics Inc. (STML) Climbed 11.4% or 1.2 To Price $11.73 On Wednesday


Stemline Therapeutics Inc. (STML) climbed 11.4% or 1.2 to $11.73. It is about 323006 shares traded, which is 140.97% compare to the average total volume 229129. The market cap of STML is $373.02 million. The year to date change is -21.32%. The 52 week price range is from $10.37 to $20.55. Price of STML have changed -7.95% during last week. It have changed -32.84% over last month, -29.33% over last 3 months, -45.86% over last 6 months and -26.11% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for STML is 15.39. It is 31.20% above current price. The 200-day Moving Averages for STML is 16.40. It is 39.81% above current price. The 52-week High is 20.55. It is 75.19% from the current price. The 52-week Low is 10.37. It is -11.59% from current price.

There are some statistics of STML. It is has market cap $373.02 million. The share outstanding is 31.80 million. The average volume is 229129. The percent of top 15 Institution holding is 100.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of STML is -123.50%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of STML is -99.06%.


Tags:

Share this post